Supplement registry would enable more effective handling of adverse events -- AAPCC.
This article was originally published in The Tan Sheet
Executive Summary
DIETARY SUPPLEMENT REGISTRY FOR POST-MARKETING SURVEILLANCE should be developed for both ingredients and products, American Association of Poison Control Centers Executive Director Toby Litovitz, MD, declared at a Feb. 11-12 meeting of FDA's Food Advisory Committee in Arlington, Va. The "single most important message" to the committee, Litovitz said, "is that without information on product ingredients and without a registry of products, no one can do effective surveillance in the U.S. no matter how much money is put into improving or developing existing or new surveillance systems."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning